Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

NCT01947790 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

LVM
Type 2 Diabetic Patients With IHD
Endothelial Function

Interventions

DRUG: pioglitazone group
DRUG: Metformin group

Sponsor

Xiang Guang-da